STOCK TITAN
  1. Home
  2. Sec-filings
  3. XRAY
  4. [Form 4] DENTSPLY SIRONA Inc. Insider Trading Activity

Director at DENTSPLY SIRONA (XRAY) granted 22,822 RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

HOSEIN CLYDE reported acquisition or exercise transactions in this Form 4 filing.

DENTSPLY SIRONA Inc. director Clyde Hosein received an equity award of 22,822 shares on June 3, 2026 at no cash cost per share. A footnote explains this grant consists entirely of restricted stock units that vest in full one year from the grant date.

After this compensation-related award, Hosein holds a total of 64,075.456 common shares directly. Because this is a stock grant rather than an open-market purchase, it reflects routine director compensation rather than a discretionary share purchase.

Positive

  • None.

Negative

  • None.
Insider HOSEIN CLYDE
Role null
Type Security Shares Price Value
Grant/Award Common Stock 22,822 $0.00 --
Holdings After Transaction: Common Stock — 64,075.456 shares (Direct, null)
Footnotes (1)
  1. [object Object]
RSU grant size 22,822 shares Restricted Stock Units granted June 3, 2026
Grant price $0.00 per share Compensation-related equity award, not market purchase
Post-grant holdings 64,075.456 shares Common stock directly owned after transaction
Vesting schedule One year from grant date RSUs vest in full after one year
Restricted Stock Units (RSUs) financial
"This grant consists entirely of Restricted Stock Units (RSUs) that vest in full"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
transaction code "A" regulatory
"transaction_code_description": "Grant, award, or other acquisition""
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HOSEIN CLYDE
(Last)(First)(Middle)
C/O DENTSPLY SIRONA INC
13320-B BALLANTYNE CORPORATE PLACE
(Street)
CHARLOTTE NORTH CAROLINA 28277
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/03/2026A22,822(1)A$064,075.456D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.
/s/ Jessica Nielsen Causey, Attorney-in-Fact for Clyde Hosein06/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did DENTSPLY SIRONA (XRAY) director Clyde Hosein report on this Form 4?

Clyde Hosein reported receiving an equity award of 22,822 common shares as compensation. A footnote clarifies the award is in the form of restricted stock units that vest in full one year after the June 3, 2026 grant date.

How many DENTSPLY SIRONA (XRAY) shares does Clyde Hosein hold after this grant?

After the reported grant, Clyde Hosein directly holds 64,075.456 shares of DENTSPLY SIRONA common stock. This total reflects his position following the June 3, 2026 restricted stock unit award reported in the Form 4 filing.

Was Clyde Hosein’s DENTSPLY SIRONA (XRAY) transaction an open-market purchase or a grant?

The transaction was a grant, not an open-market purchase. The Form 4 uses transaction code “A” for an award and shows a price of $0.00 per share, indicating a compensation-related restricted stock unit grant rather than a market buy.

What are the vesting terms of Clyde Hosein’s RSU grant at DENTSPLY SIRONA (XRAY)?

The restricted stock units vest in full one year after the grant date. The footnote states the award consists entirely of RSUs whose restrictions lapse in a single tranche, providing straightforward, time-based vesting for the director.

Does this DENTSPLY SIRONA (XRAY) Form 4 show any stock sales by Clyde Hosein?

The Form 4 does not report any stock sales by Clyde Hosein. It shows a single acquisition-type transaction coded “A” for 22,822 shares, reflecting a restricted stock unit grant with no corresponding disposition or sale recorded.